Tevogen Bio Holdings Inc
TVGN0.994USD
-0.006-0.61%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
182.75MMarket Cap
LossP/E TTM
Tevogen Bio Holdings Inc
0.994
-0.006-0.61%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-52.88%-3.31M
-54.20%-3.05M
-111.37%-3.80M
-34.50%-2.98M
0.61%-2.16M
27.78%-1.98M
10.32%-1.80M
---2.22M
---2.18M
---2.74M
---2.01M
Net income from continuing operations
-192.03%-10.37M
-160.02%-9.44M
-50.69%-5.88M
56.44%-9.66M
136.63%11.26M
36.57%-3.63M
20.05%-3.90M
---22.18M
---30.76M
---5.73M
---4.88M
Operating gains losses
0.00%40.55K
-8.03%40.55K
2.06%40.55K
2.05%40.55K
2.06%40.55K
-20.80%44.09K
1795.75%39.73K
--39.74K
--39.73K
--55.67K
--2.10K
Other non-cash items
-99.19%64.85K
10.96%62.99K
-682.82%-313.81K
2400.59%1.32M
15358.77%7.96M
13.50%56.77K
10.15%53.84K
--52.97K
--51.47K
--50.02K
--48.88K
Change in working capital
-167.55%-349.82K
-999.77%-749.04K
-366.26%-1.15M
1191.87%1.37M
828.01%517.84K
85.64%-68.11K
-36.90%431.38K
---125.87K
--55.80K
---474.32K
--683.60K
-Change in receivables
----
----
----
----
----
---267.00K
----
----
----
----
----
-Change in prepaid expenses
90.02%-24.97K
123.19%119.13K
121.12%114.34K
-410.27%-229.35K
-454.52%-250.12K
-481.96%-513.79K
299.29%51.71K
--73.92K
--70.55K
---88.28K
---25.95K
-Change in payables and accrued expense
----
----
----
----
----
--931.95K
----
----
----
----
----
-Change in other current assets
----
-246.35%-442.56K
--0.00
100.00%0.00
-420.68%-68.45K
286.67%302.40K
100.00%0.00
---1.00
--21.34K
---162.00K
---42.01K
Cash from non-recurring investing activities
Cash from operating activities
-52.88%-3.31M
-54.20%-3.05M
-111.37%-3.80M
-34.50%-2.98M
0.61%-2.16M
27.78%-1.98M
10.32%-1.80M
---2.22M
---2.18M
---2.74M
---2.01M
Investing cash flow
Net cash from continuing investing activities
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--133.00K
--165.39K
--126.64K
Capital expenditures
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--133.00K
--165.39K
--126.64K
Net cash flow from disposal of fixed assets
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--133.00K
--165.39K
--126.64K
Net cash flow from investment products
----
----
----
----
----
--342.92M
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---133.00K
---165.39K
---126.64K
Financing cash flow
Cash flow from continuous financing activities
64.65%4.00M
373.65%2.00M
426.32%5.00M
--2.80M
-2.83%2.43M
-83.11%422.25K
--950.00K
--0.00
--2.50M
--2.50M
--0.00
Net cash flow from debt Issuance/repayment
--4.00M
-100.00%0.00
-13.04%1.00M
--0.00
-100.00%0.00
60.00%4.00M
--1.15M
--0.00
--2.50M
--2.50M
--0.00
Net cash flow from common stock issuance/repurchase
----
----
----
----
----
---3.65M
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
--2.00M
--4.00M
--2.80M
--2.20M
----
----
----
----
----
----
Net cash flow from other financing activities
----
-100.00%0.00
100.00%0.00
--0.00
--229.33K
--72.25K
---200.00K
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
64.65%4.00M
373.65%2.00M
426.32%5.00M
--2.80M
-2.83%2.43M
-83.11%422.25K
--950.00K
--0.00
--2.50M
--2.50M
--0.00
Net cash flow
Beginning cash balance
21.91%1.28M
-10.59%2.33M
-67.15%1.14M
-76.77%1.32M
-80.81%1.05M
-55.72%2.61M
-56.90%3.46M
--5.67M
--5.48M
--5.89M
--8.02M
Current period cash flow changes
160.61%691.94K
32.59%-1.05M
240.62%1.20M
91.77%-182.51K
39.84%265.50K
-286.43%-1.55M
60.17%-849.99K
---2.22M
--189.87K
---402.19K
---2.13M
Ending cash balance
49.85%1.97M
21.91%1.28M
-10.59%2.33M
-67.15%1.14M
-76.77%1.32M
-80.81%1.05M
-55.72%2.61M
--3.46M
--5.67M
--5.48M
--5.89M
Free cash flow
----
----
----
----
6.33%-2.16M
31.90%-1.98M
15.64%-1.80M
---2.22M
---2.31M
---2.90M
---2.13M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
